Breast Cancer Now

110.5k citations
1.5k papers ·

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 2%
    • PARP inhibition in cancer therapy
    • Cancer Cells and Metastasis
    • Cancer-related Molecular Pathways
    • HER2/EGFR in Cancer Research

Papers in

    • Breast Cancer Treatment Studies 173
    • Cancer Genomics and Diagnostics 129
    • Cancer Cells and Metastasis 128
    • Cancer-related Molecular Pathways 100
    • HER2/EGFR in Cancer Research 99
    • PARP inhibition in cancer therapy 91

Breast Cancer Now

1.4k papers receiving 98.5k citations

Peers

Breast Cancer Now
Comparison fields: 5 of 211
  • Cancer Research 25.5k
  • Oncology 42.8k
  • Molecular Biology 54.7k
  • Immunology 10.4k
  • Pathology and Forensic Medicine 8.1k
Replace Cancer Research UK Cambridge Center with:
Cancer Research UK Cambridge Center United Kingdom
CRUK Lung Cancer Centre of Excellence United Kingdom
Wellcome/MRC Cambridge Stem Cell Institute United Kingdom
Hutchison/MRC Research Centre United Kingdom
Ludwig Cancer Research United Kingdom
MRC Weatherall Institute of Molecular Medicine United Kingdom
The Gurdon Institute United Kingdom
La Ligue Contre le Cancer France
Laboratoire d’immunologie intégrative du cancer France
Institut thématique Génétique, génomique et bioinformatique France
Breast Cancer Now relative to Cancer Research UK Cambridge Center United Kingdom Cancer Research UK Cambridge Center's profile →
Citations per field
00.5×1.5×2.2×
Cancer Research UK Cambridge Center · 1×
Citations per year

Countries citing scholars working at Breast Cancer Now

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Breast Cancer Now. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Breast Cancer Now with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Breast Cancer Now more than expected).

Fields of papers published by authors at Breast Cancer Now

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Breast Cancer Now at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Breast Cancer Now at the time of their publication.

About Breast Cancer Now

In recent decades, authors affiliated with Breast Cancer Now have published 1.5k papers, which have received a total of 110.5k indexed citations . Scholars at this organization have produced 364 papers in Cancer Research, 561 papers in Oncology, 685 papers in Molecular Biology, 242 papers in Genetics and 169 papers in Immunology on the topics of Breast Cancer Treatment Studies (173 papers), Cancer Genomics and Diagnostics (129 papers), Cancer Cells and Metastasis (128 papers), Cancer-related Molecular Pathways (100 papers), HER2/EGFR in Cancer Research (99 papers), DNA Repair Mechanisms (98 papers), PARP inhibition in cancer therapy (91 papers) and Estrogen and related hormone effects (86 papers). Their work is cited by papers focused on Cancer Research (25.5k citations), Oncology (42.8k citations), Molecular Biology (54.7k citations), Immunology (10.4k citations) and Pathology and Forensic Medicine (8.1k citations). Authors at Breast Cancer Now collaborate with scholars in United Kingdom, United States and Italy and have published in prestigious journals including Breast Cancer Research, British Journal of Cancer, Cancer Research, Breast Cancer Research and Treatment and The Journal of Pathology. Some of Breast Cancer Now's most productive authors include Alan Ashworth, Christopher J. Lord, Nicholas C. Turner, Jorge S. Reis‐Filho, Andrew Tutt, Pascal Meier, Alan Ashworth, Richard Grose, Clare M. Isacke and Mitch Dowsett.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact